# Miton UK MicroCap Trust reports best annual performance of the Trust in its six year life

- Link: https://www.directorstalkinterviews.com/miton-uk-microcap-trust-reports-best-annual-performance-of-the-trust-in-its-six-year-life/4121007698
- Published: 2021-07-06T07:42:03+01:00
- Author: Giles

**[Miton UK MicroCap Trust plc](https://www.directorstalkinterviews.com/company/miton-uk-microcap-trust-plc/mini.l)**(
[LON:MINI](https://www.directorstalkinterviews.com/company/miton-uk-microcap-trust-plc/mini.l))
has today provided its annual report for the year ended 30 April 2021. The full 
Report and Accounts will be available via the Company’s website, www.mitonukmicrocaptrust.
com, or by contacting the Company Secretary on 01392 477500.

Miton UK MicroCap Trust plc is an investment trust quoted on the London Stock Exchange
under the ticker code MINI. It is referred to as the Company, MINI or the Trust 
in the text of this Report. The Board, which consists of five independent Directors,
appoints the Investment Manager and is responsible for monitoring the Trust’s performance.

**STRATEGIC REPORT**

**RESULTS FOR THE YEAR TO 30 APRIL 2021**

 * Over the year, the Ordinary share NAV moved from 51.33p on 30 April 2020 to 104.83p
   on 30 April 2021, a total return including dividends reinvested of 104.4%.

 * The Ordinary share price moved from 43.35p at 30 April 2020 to 104.50p at 30 
   April 2021, a total return including dividend reinvested of 141.5%. As at close
   of business on 2 July 2021, the closest date to this Report, the Ordinary share
   NAV was 103.20p and the share price was 94.00p.

 * The net Revenue return was a loss of £169,000 this year (0.14p) per share as 
   costs were greater than the revenue received. This compares to a positive revenue
   return of £81,000 last year, or 0.06p per share.

 * The Company offers all investors the opportunity to redeem their shareholding
   each year, which has the advantage of clearing any overhanging sellers and is
   designed to ensure that the market price of the Company does not deviate too 
   far from the underlying NAV. Redemption requests in relation to 2,671,198 ordinary
   shares, or 2.4% of the Company’s share capital, at 30 April 2021, were received
   for the 30 June 2021 Redemption Point and are not reflected in the summary below.
   The redemption mechanism is explained further below.

 * The Company does not have a formal benchmark but, for comparison, it is intended
   that the return on the FTSE AIM All Share Index and the Morningstar Investment
   Trust UK Smaller Companies sector will be published on the monthly factsheet 
   and in the Company’s annual and interim reports. Returns may diverge from any
   of these indices for a significant period.

**SUMMARY OF RESULTS**

| 
| 
 |  | 30 April 2021 |  | 30 April 2020 | 
| Total net assets attributable to equity shareholders (£’000)^(1) |  | 116,651   |  | 71,011    |  | 
| NAV per Ordinary share^(*) |  | 104.83p  |  | 51.33p   |  | 
| Share price (mid) |  | 104.50p  |  | 43.35p   |  | 
| Premium/(Discount) to NAV^(*) |  | (0.31%) |  | (15.55)% |  | 
| Investment income |  | £0.7m |  | £0.8m  |  | 
| Revenue return per Ordinary share |  | (0.14)p |  | 0.06p  |  | 
| Total return per Ordinary share^(*) |  | 49.51p  |  | (4.67)p |  | 
| Ongoing charges^(#*) |  | 1.60% |  | 1.68% |  | 
|  |  |  |  |  |  | 
| Ordinary shares in issue |  | 111,274,758  |  | 138,335,915  |  |

*Alternative Performance Measure (APM) Details are provided in the Glossary below.

#The ongoing charges are calculated in accordance with AIC guidelines.

**CHAIRMAN’S STATEMENT**

This report covers the sixth year of the Trust ending 30 April 2021, which was a
period of robust stock market recovery as central banks and governments flooded 
their economies with plentiful liquidity to offset the effects of the Covid pandemic.

**Returns over the year**

In May 2020, many UK-quoted microcaps started the Trust’s year standing at very 
overlooked valuations as many investors had steered clear of UK domestic stocks 
during the uncertain period leading up to the Brexit Agreement. Furthermore, most
UK quoted microcap share prices had fallen yet further at the start of the global
pandemic.

Over the year to April 2021, global stock markets appreciated robustly. UK smallcap
indices performed particularly strongly with the FTSE SmallCap Index (excluding 
Investment Companies) up 69.5% in total return terms, and the FTSE AIM All Share
Index up 59.8%. The Net Asset Value (“NAV”) total return on the same basis of the
Trust was 104.6% over the same period, which includes last year’s final dividend
payment approved by shareholders at the AGM. This was the best annual performance
of the Trust in its six year life.

A proportion of the Trust’s annual running costs are set against revenue (principally
dividend income). In the past, these figures have been quite similar in magnitude
and it has always been anticipated that capital appreciation would be the principal
driver of the Trust’s return. During the year under review, numerous UK quoted companies
reduced or ceased paying dividends, so this year the costs were greater than the
dividend revenue received. The NAV total return outlined above includes a revenue
deficit per share of 0.20p for the year, which compares to a revenue surplus of 
0.06p per share last year.

**Returns since the Trust was first listed in April 2015**

In six years since the Trust was first listed, the UK stock market has been through
a fairly turbulent period. From June 2016 onwards, the UK decision to leave the 
EU initiated a long period of uncertainty. The weakness of UK-quoted microcap share
prices was further compounded by the added impact of the global pandemic.

Over the six year period, in capital terms, the FTSE All Share Index has only appreciated
6.0% despite the Brexit agreement in December, although with six years of dividend
income its total return over the period was 32.0%. Quoted smallcaps have outperformed
this Index, with the total return of the FTSE SmallCap Index (excluding Investment
Trusts) being 71.3% and that of the FTSE AIM All Share Index being 84.1% despite
the uncertainties over the six year period. The Trust’s NAV total return including
dividend income paid to shareholders over the same period was 118.0%.

**Share Redemptions**

Since the Trust’s share price reflects the balance of buyers and sellers, when there
is an imbalance, the Trust’s share price can diverge from its NAV.

Over the year to April 2021 the Trust’s share price discount to its daily NAV averaged
9.5%. As investors became more upbeat about the Trust’s prospects and the Brexit
uncertainties fell away, the Trust’s share price discount narrowed, and the Trust
finished the year with its share price much in line with its NAV.

In order to help to address any persistent imbalances between buyers and sellers,
the Trust offers all shareholders the option to redeem their shares each year.

This year, redemption requests were made over 2,671,198 shares at the closing date
of 2 June 2021. As announced on 30 June, the Board resolved that these shares would
be redeemed for cash at a value of 102.38 pence per share, to be settled on or around
14 July 2021.

**Board changes**

As announced with the half year results, Bridget Guerin was appointed to the Board
from 1 December 2020.

**Prospects**

The yield on government debt has progressively fallen over the decades, which has
been a tailwind for the share prices of major technology stocks,

growth equities and other long duration assets. Yet over recent months, the prior
trend appears to have been breaking down. Whilst global stock markets have continued
to rise this year, the share prices of UK microcaps have tended to outperform ahead
of most others.

The recent trend aligns with those of earlier decades, when the mainstream UK indices
outperformed the US exchange for an extended period, and the share prices of UK 
microcaps outperformed substantially. Whilst we shouldn’t necessarily expect UK 
microcaps to outperform every year, this sector appears well-placed for a period
of premium returns.

Andy Pomfret

Chairman

5 July 2021

**INVESTMENT MANAGER’S REPORT**

**Who are the fund managers of the Trust?**

Premier Miton Group plc is an independent, listed fund management company, formed
from the merger of Premier Asset Management and Miton Group in November 2019, with
a well established reputation for successfully managing UK-quoted smaller company
portfolios over the longer term. The Trust’s board appointed Miton Group as Investment
Manager when it was listed in April 2015.

The day-to-day management of the Trust’s portfolio continues to be carried out by
Gervais Williams and Martin Turner, who came together as a team in April 2011.

**Gervais Williams**

Gervais joined Miton in March 2011 and is now Head of Equities at Premier Miton.
He has been an equity fund manager since 1985, including 17 years at Gartmore. He
was named Fund Manager of the Year by What Investment? in 2014. Gervais is also 
a board member of the Quoted Companies Alliance and a member of the AIM Advisory
Council.

**Martin Turner**

Martin joined Miton in May 2011. Martin and Gervais have had a close working relationship
since 2004, with complementary expertise that led them to back a series of successful
companies. Martin qualified as a Chartered Accountant with Arthur Anderson and had
senior roles and extensive experience at Merrill Lynch and Collins Stewart.

**What were the main contributors to the Trust’s outperformance over the year?**

The year to April 2021 was a period when numerous share prices around the world 
recovered from the pandemic setback, and often moved to new highs. The total return
on the FTSE SmallCap Index (excluding investment companies) index was 69.5% and 
the FTSE AIM All Share Index was 59.8%.

Whilst economic conditions were challenging for some companies during the global
pandemic, for others the nature of change offered them much greater potential than
before. In the case of [Avacta](https://www.directorstalkinterviews.com/company/avacta-group-plc/avct.l)
for example, they found their affimer technology which may significantly reduce 
the side effects of chemotherapy in time, was also potentially very suited to use
in lateral flow tests for Covid. Synairgen found that their treatments that helped
asthmatics combat the cold virus, turned out to be very helpful to lessen the disease
for those with shortness of breath due to Covid.

The abrupt reduction in demand during the pandemic-induced recession, followed by
an equally abrupt renewed surge of demand with the economic stimulus, has led to
shortage of certain materials, such as copper, leading to a very strong share price
appreciation of Jubilee Metals in the year. The appreciation of asset prices was
particularly evident amongst cryptocurrencies, and this led to a very substantial
rise in the share price of Argo Blockchain.

One of the features of quoted microcaps, is that they start with modest market capitalisations.
The potential upside from the changes in their markets can drive up their share 
prices by multiples of the price at purchase. The four stocks above, contributed
over 27% of the Trust’s total returns of 104.4% during the year to April.

Clearly there were some holdings that detracted from the Trust’s return during the
year. The most disappointing was Kromek Group, a company which is improving the 
images of medical scanners, and also identifies radioactive substances for the security
forces. In the case of Kromek, they were unable to deliver a major order due to 
the pandemic travel restrictions, so the potential cash payback has been deferred.
The Trust has largely exited from the holding, although it still detracted 0.9% 
in the year. There were not many other significant detractors, although collectively
7 Digital, Tekmar Group, Microsaic Systems and TP Group detracted 1.0% from the 
Trust’s return in the year.

**Why was the Trust’s revenue per share negative over the year?**

The Trust’s strategy particularly seeks to identify quoted microcaps that are well
positioned to generate a plentiful surplus of cash in the short to medium-term. 
As these stocks mature, their cash surpluses put them in a position to either step
up reinvestment in their business, or to start paying initial and growing dividends
to investors. When the Trust’s holdings succeed and they are in a position to start
paying significant dividends to investors, their share prices have normally also
risen substantially. In many cases, they have grown to beyond being microcaps, and
may have lesser prospects for substantial share price appreciation. Therefore, it
is usual for these holdings with dividend income to be sold from the Trust’s portfolio,
so the capital can be reinvested in a number of other immature microcaps with much
greater potential upside.

Since dividend income contributes the bulk of Trust’s revenue each year, and as 
the Trust normally takes profits on these stocks, the overall annual revenue is 
relatively modest. During the global recession, numerous companies opted either 
to hold back from paying dividends, or in some cases cut their prior distributions,
so the Trust’s revenue fell during the year under review.

The Trust’s principal cost is the management fee, with one quarter of this figure
expensed against the Trust’s revenue, and three quarters expensed against

the Trust’s NAV each year. Since the Trust’s revenue per share is relatively modest,
it was slightly smaller than its revenue expenses to the extent that the revenue
deficit per share for the year under review was 0.2p, which compares with a revenue
surplus of 0.06p last year. The Directors have determined that the remaining revenue
reserves should paid as a dividend to shareholders this year. The Directors have
determined that a final dividend of 0.01p should be recommended to shareholders 
for approval at this year’s AGM. As the revenue per share is in deficit this year,
this dividend has been funded from past revenue reserves.

It has always been envisaged that the bulk of the Trust’s return would be via capital
appreciation. Over the six years since the Trust was first listed, the aggregate
appreciation of the NAV has been 56p, whilst the net revenue per share that funds
the Trust’s dividend in aggregate has been just 2p.

**What are the main factors that have driven the Trust’s returns since it first 
listed in April 2015?**

In the UK, an analysis of stock market data since 1955 reveals that the best performing
group of stocks has been quoted microcaps, and, most especially, when combined with
a bias towards those standing on low, overlooked valuations. Whilst stocks with 
these characteristics have not outperformed continuously, their strong performance
has been a persistent trend through a variety of economic and stock market conditions.
For this reason, the Trust’s strategy focuses on quoted microcaps that are standing
on overlooked valuations. When these succeed, their share prices can rise by much
greater percentages than most mainstream stocks, as they did in the year under review.

In the past, the rise of the share prices of overlooked microcaps have often lagged
the returns of higher profile, more volatile stocks at times of abundant market 
liquidity. Yet eventually, the share prices of stocks that are forecast to grow 
strongly tend to be more vulnerable when economic conditions change. The dot.com
boom prior to the millennium is a good example of how much the share prices of stocks
that are forecast to grow rapidly can appreciate, but it is also a good example 
of how quickly and hard they can subsequently fall.

Over the six years since the Trust’s IPO, the share prices of stocks that are forecast
to grow rapidly have often been the best performers, although many of the stocks
in the Trust’s portfolio on lower valuations have also performed well in the year
under review as their prospects greatly improved with the changing economic and 
market trends of the pandemic. Furthermore, to some degree, as the open-ended nature
of the Brexit uncertainty has come to an end, investors are more willing to contemplate
investing in UK quoted microcaps.

Overall, we believe that the true potential of the Miton UK Micro Cap Trust strategy
has not yet been fully evident. Even so, the Trust’s NAV total return over the six
years to April 2021 was 118.0% which equates to an annualised total return of 13.9%
per annum. This compares favourably with the returns on the various UK smaller company
indices.

Although the Trust has delivered a major increase in NAV over the last year, we 
continue to believe that the prospects for a strategy seeking to participate in 
the outperformance of UK quoted microcaps standing on overlooked valuations, is 
still overdue a period of performance catch-up compared to stocks that are already
standing on elevated valuations because they are forecast to grow strongly.

**How is the climate change agenda reflected in the Trust’s portfolio?**

Whilst some fund strategies are dedicated to investing solely in low-carbon companies
that are already close to meeting the climate change agenda, the interconnected 
nature of the corporate world means that many of these still have a reliance on 
others that are less well aligned. Specifically, we believe that the financial markets
have a major role in actively engaging with the less-aligned companies. Specifically,
each needs to make an assessment of their current carbon footprints and then plan
to steadily reduce it in future. Normally, evolving a business towards a zero carbon
future, will involve very substantial investment, so access to capital will be an
important component of these plans.

As managers of the Miton UK Microcap Trust we have a long history of actively highlighting
areas of potential hazard with the management teams of quoted companies, so that
they can be considered, and, if they agree with us, the risks moderated. In that
regard, we actively quiz management teams as to how they are planning to address
the climate change agenda, and often give best practice examples of others’ actions.
This strategy does involve investing and engaging with some companies that currently
have poor metrics, on the basis that reductions in the carbon footprints of these
kinds of companies are essential for the UK economy as a whole to meet its zero 
carbon commitment.

In our opinion, progressively over time, many of the current activities of businesses
will either become unviable as the cost of carbon emissions becomes prohibitive,
or customer preferences result in a vertiginous decline in demand. Thus, all companies
will need to embrace change and step up investment, so they remain sustainable in
all senses of the word. For some, moving ahead of others may well offer commercial
advantage, and hence enhanced returns. Conversely, some may misjudge how quickly
others respond, and carry the associated downside risks. The bottom line is that
the Trust’s portfolio still has shareholdings in all sorts of businesses that we
genuinely believe embrace the need for change and, in our view, will be successful
at addressing the climate change agenda. If they succeed and progressively lower
their carbon footprints, then we believe this progress will not only actively assist
the UK to become a low carbon economy, but also deliver premium returns for shareholders
as well.

**What impact would a sustained pick up in global inflation have on the Trust?**

Following the surge of economic stimulus during the global pandemic, it is evident
that there are all sorts of industry constrictions that are now leading to renewed
inflationary pressures. At this stage, it is unknown whether these bottlenecks will
prove to be temporary or long-term in nature.

If inflation does prove to be more embedded, then the yields of long-dated bonds
will probably rise, which could weigh on the valuations of all asset prices, including
stock markets. At the margin, a rise in long-dated bonds might make it harder for
some companies with major debt burdens, or those that operate at a loss over many
years, to access borrowings when their current facilities expire. Most of the stocks
in the Trust’s portfolio would be largely unaffected, as they tend to have strong
balance sheets with little debt and are not expected to be persistently loss making.

If inflation does become entrenched, then at the time of an economic downturn it
might reduce the scope for central banks or governments to inject economic stimulus
in future. Such a change might put more companies at risk of insolvency. One of 
the advantages of being listed, is that companies can raise external capital and
acquire previously overborrowed, but otherwise viable businesses from the receiver.
These kinds of acquisitions often bring in additional skilled staff and generate
attractive returns on investment, greatly enhancing the prospect of generating plentiful
cash in the future. Sometimes these transactions can be potentially transformative
for quoted microcaps, because they can be substantial relative to their diminutive
size.

Overall, whilst a sustained increase in inflation would, to some degree, make it
harder for nearly all businesses, generally we believe that quoted microcaps have
some offsetting factors that could greatly enhance their prospects.

**How unusual is the UK quoted microcap investment universe?**

Prior to a sustained period of globalisation, returns on mainstream stock markets
were not very different from that of underlying inflation. During these decades,
institutions actively chose to allocate capital to the UK-quoted small and microcaps
universe because they needed to access the premium returns they offered.

During the period of globalisation, however, asset returns of all kinds have been
unusually plentiful, so institutional interest for quoted small and microcap stocks
was crowded out by larger weightings in long-duration assets such as US technology
growth stocks. Over recent decades, many small and microcap stock markets around
the world have closed for lack of institutional interest.

In contrast to others, the UK government has sustained the support for a quoted 
small and microcap exchange via dedicated tax exemptions, because they generate 
both more skilled employment and increased productivity than mainstream companies,
and ultimately contribute additional tax take. Hence, as the ultra-low yields on
bonds depress the prospective returns on most mainstream assets, the premium returns
on quoted small and microcaps is likely to lead to renewed interest from institutional
investors.

Generally, we believe that the prospects for the UK economy may not differ much 
from others, but the vibrant universe of UK quoted small and microcaps imply its
prospective returns could be very different. Almost half of all the companies listed
in the UK have a market capitalisation of less than £150m which is a major point
of difference for the UK market compared with most others.

**What are the prospects for the Trust?**

The valuation of government debt around the world has risen considerably, in a trend
that has persisted for decades. The valuation of the full range of assets has also
increased, with the valuations of numerous technology companies and unicorn stocks
probably rising the most. Since the US has so many quoted businesses with rapid 
growth expectations like these, the valuation of the US stock market as a whole 
has risen more than others, and it has delivered outstanding returns over recent
decades.

The UK stock market mainly comprises companies that tend to grow less rapidly. Hence,
the valuation of the UK stock market has not risen as much as the US. Furthermore,
the uncertainties of the Brexit over the last five years has also suppressed investor
enthusiasm, and so the valuation of all sorts of UK quoted microcaps are still undemanding,
even after the recent period of performance catch-up.

Following the global pandemic, the whipsaw in global demand has led to shortages
of supply in a wide range of individual products. This has initiated a period of
inflation, and the valuation of government debt has peaked out somewhat. The recent
reversal in bond valuations tends to favour profitable companies that generate surplus
cash, as they have greater resilience than technology companies that often need 
plentiful capital to fund their growth. The recent period has also favoured younger
businesses, as many of these operate in immature sectors, where prospects are less
reliant on ongoing global growth. The Trust’s portfolio includes numerous younger
businesses that are anticipated to generate substantial surplus cash, and hence 
the recent economic and market trends have been reflected in a period of substantial
outperformance. Specifically, it is reassuring to note just how well the Miton UK
Microcap Trust’s strategy can perform at a time of disappointing global growth and
rising inflationary pressures.

Inflationary pressures may fluctuate over the coming quarters, and the stock exchanges
themselves might oscillate as the market trend of recent decades runs out. In time,
we expect the forthcoming market trends to resemble those of the decades prior to
globalisation, when UK quoted microcaps substantially outperformed. The Miton UK
Microcap Trust’s strategy was set up in anticipation of this potential. If the economic
and market patterns are fundamentally changing, then the Trust’s strategy is well-
set to deliver a long period of premium returns.

Gervais Williams and Martin Turner

5 July 2021

**BUSINESS MODEL**

**Business and Status of the Company**

MINI was incorporated on 26 March 2015 and its Ordinary shares were listed on the
London Stock Exchange on 30 April 2015. It is registered in England as a public 
limited company and is an investment company in accordance with the provisions of
Sections 832 and 833 of the Companies Act 2006.

The principal activity of the Company is to carry on business as an investment trust.
The Company intends at all times to conduct its affairs so as to enable it to qualify
as an investment trust for the purposes of Sections 1158/1159 of the Corporation
Tax Act 2010 (“S1158/1159”). The Directors do not envisage any change in this activity
for the foreseeable future. The Company has been granted approval from HM Revenue&
Customs (“HMRC”) as an investment trust under S1158/1159 and will continue to be
treated as an investment trust company, subject to there being no serious breaches
of the conditions for approval.

The principal conditions that must be met for continuing approval by HMRC as an 
investment trust are that the Company’s business should consist of “investing in
shares, land or other assets with the aim of spreading investment risk and giving
members of the company the benefit of the results” and the Company may only retain
15% of its investment income. The Company must also not be a close company. The 
Directors are of the opinion that the Company has conducted its affairs for the 
year ended 30 April 2021 so as to be able to continue to qualify as an investment
trust.

The Company’s status as an investment trust allows it to obtain an exemption from
paying taxes on the profits made from the sale of its investments and all other 
net capital gains. Investment trusts offer a number of advantages for investors,
including access to investment opportunities that might not be open to private investors
and to professional stock selection skills at lower cost, and the ability to hold
illiquid positions in uncertain market conditions.

**Investment Policy**

The Company’s full investment policy is set out in the full report and contains 
information on the policies which the Company follows relating to asset allocation,
risk diversification and gearing, and includes maximum exposures, where relevant.
The Company invests in a portfolio of UK quoted companies with the objective of 
achieving capital growth by investing in a portfolio of stocks that are well placed
to generate an attractive cash payback from productivity improvements.

Share on:
